News

Investors

Keen Eye Closed Series A Fundraising

April 29, 2019, PARIS – KEEN EYE, a company that designs, develops and markets machine learning solutions for the research and biomedical sectors, announces today that it has finalized a EUR 6 million fundraising led by CM-CIC Innovation and with the Quadrivium 1 Seeding Fund, managed by Seventure Partners, its historical partner. This investment was […]

Partners

HalioDx and KEEN EYE partner to empower IMMUNOSCORE® with Artificial Intelligence

November 8, 2018, PARIS – HalioDx, an immuno-oncology diagnostic company pioneering the immunological diagnosis of cancers with Immunoscore® and Keen Eye, an innovative company specialized in image analysis technologies based on artificial intelligence announced today a strategic partnership to develop a cloud-based platform and applications. The partnership will create the very first cloud-based computational pathology […]

Partners

KEEN EYE and Iris Pharma Team up to Bring Artificial Intelligence in Ophthalmology Studies

October 2018, PARIS – Keen Eye, a French technology company specialized in image analysis for the life science industry, announced today a strategic partnership agreement with Iris Pharma, a world-wide leading ophthalmology-focused contract research organization (CRO) that offers preclinical and clinical drug / device development services. The partnership aims at providing Iris Pharma artificial intelligence […]

Investors

Keen Eye Raises €1.5 Million from Seventure Partners’ Quadrivium 1 Seed Fund

December 12, 2016, PARIS – Keen Eye will finalize the development of its innovative image interpretation platform for laboratories and biomedical research   Keen Eye, a company that designs, develops and markets innovative image analysis solutions for research and the medical sector, announced today a 1.5 million fund raising from Seventure Partners’ Quadrivium seed fun. […]